grafic lines 1

Delivering the Power of Sight

Transforming ophthalmology and optometry by addressing the underlying causes of the world’s most prevalent eye diseases.

About the Company

Sight Sciences is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease.
Founded in 2011, the company has developed, and is now commercial with intelligently designed and engineered products that target the underlying causes of the world’s most prevalent eye diseases. The company’s surgical glaucoma product portfolio features the OMNI™ Glaucoma Treatment System, a dually-indicated device that facilitates the performance of both trabeculotomy and transluminal viscoelastic delivery. The company’s non-surgical Dry Eye product portfolio consists of TearCare® which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.
grafic lines 3

OMNI Glaucoma Treatment System – an implant free MIGS device that targets all three points of resistance

OMNI Glaucoma Treatment System – an implant free MIGS device that targets all three points of resistance

For MIGS-trained surgeons, OMNI™ is a single intelligently designed MIGS device that combines two implant-free titratable procedures and effectively targets all three points of resistance in the conventional outflow pathway, with or without cataract surgery.
VISIT OMNI WEBSITE
button play
Watch OMNI Video

Glaucoma

The world's #1 cause of irreversible blindness.

News

Inquire

For all inquiries, please complete the following form.
Area of Interest (check all that apply)
Submit